47 Biggest Movers From Yesterday
Gainers
Nuvectis Pharma, Inc. (NASDAQ: NVCT) shares surged 144.6% to close at $7.95 on Monday. The company, on Friday, priced its IPO at $5 per share.
Evercore ISI Group Initiates Coverage On Amylyx Pharmaceuticals with Outperform Rating
Evercore ISI Group analyst Umer Raffat initiates coverage on Amylyx Pharmaceuticals (NASDAQ:AMLX) with a Outperform rating.
Goldman Sachs Initiates Coverage On Amylyx Pharmaceuticals with Buy Rating, Announces Price Target of $36
Goldman Sachs analyst Chris Shibutani initiates coverage on Amylyx Pharmaceuticals (NASDAQ:AMLX) with a Buy rating and announces Price Target of $36.
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
The broader market weakness pervaded into the biotech sector in the week ending Jan. 28, sending stocks lower.
48 Biggest Movers From Yesterday
Gainers
Splash Beverage Group, Inc. (NYSE: SBEV) shares jumped 70.6% to close at $1.80 on Tuesday after the company announced it received authorization to sell its TapouT performance drink in Walmart stores across Florida metropolitan areas.
Barron’s Latest Picks And Pans: Visa, AT&T, Biogen, Robinhood And More
This weekend's Barron's cover story says commodities may not be as exciting as crypto or tech stocks, but they could be the right investment at the right time.
The Daily Biotech Pulse: Glaukos Gets FDA Nod, Neurocrine Preannounces Soft Ingrezza Sales, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.